Compass Wealth Management LLC Makes New $1.67 Million Investment in CME Group Inc. $CME

Compass Wealth Management LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CMEFree Report) during the second quarter, Holdings Channel reports. The institutional investor acquired 7,570 shares of the financial services provider’s stock, valued at approximately $1,672,000.

Other hedge funds have also modified their holdings of the company. Whipplewood Advisors LLC boosted its holdings in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership purchased a new stake in CME Group during the 4th quarter worth about $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group in the 4th quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of CME Group in the 2nd quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID boosted its stake in shares of CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research report on Thursday, July 23rd. The Goldman Sachs Group dropped their target price on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. UBS Group cut their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research note on Monday, July 6th. Piper Sandler decreased their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Finally, Barclays lowered their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Ten investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $291.81.

Get Our Latest Analysis on CME Group

CME Group Trading Up 1.4%

NASDAQ:CME opened at $271.54 on Wednesday. The stock has a fifty day moving average price of $250.82 and a two-hundred day moving average price of $279.97. The stock has a market capitalization of $97.64 billion, a price-to-earnings ratio of 23.03, a PEG ratio of 3.14 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the company posted $2.96 earnings per share. As a group, sell-side analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is presently 44.11%.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.